Purification of recombinant bacterial collagens containing structural perturbations.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
03
2023
accepted:
02
05
2023
medline:
19
5
2023
pubmed:
17
5
2023
entrez:
17
5
2023
Statut:
epublish
Résumé
Streptococcus pyogenes-derived recombinant bacterial collagen-like proteins (CLPs) are emerging as a potential biomaterial for biomedical research and applications. Bacterial CLPs form stable triple helices and lack specific interactions with human cell surface receptors, thus enabling the design of novel biomaterials with specific functional attributes. Bacterial collagens have been instrumental in understanding collagen structure and function in normal and pathological conditions. These proteins can be readily produced in E. coli, purified using affinity chromatography, and subsequently isolated after cleavage of the affinity tag. Trypsin is a widely used protease during this purification step since the triple helix structure is resistant to trypsin digestion. However, the introduction of Gly→X mutations or natural interruptions within CLPs can perturb the triple helix structure, making them susceptible to trypsin digestion. Consequently, removing the affinity tag and isolating collagen-like (CL) domains containing mutations is impossible without degradation of the product. We present an alternative method to isolate CL domains containing Gly→X mutations utilizing a TEV protease cleavage site. Protein expression and purification conditions were optimized for designed protein constructs to achieve high yield and purity. Enzymatic digestion assays demonstrated that CL domains from wild-type CLPs could be isolated by digestion with either trypsin or TEV protease. In contrast, CLPs containing Gly→Arg mutations are readily digested by trypsin while digestion with TEV protease cleaved the His6-tag, enabling the isolation of mutant CL domains. The developed method can be adapted to CLPs containing various new biological sequences to develop multifunctional biomaterials for tissue engineering applications.
Identifiants
pubmed: 37196046
doi: 10.1371/journal.pone.0285864
pii: PONE-D-23-06762
pmc: PMC10191275
doi:
Substances chimiques
Trypsin
EC 3.4.21.4
Collagen
9007-34-5
Recombinant Proteins
0
Bacterial Proteins
0
Biocompatible Materials
0
Recombinant Fusion Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0285864Informations de copyright
Copyright: © 2023 Gahlawat et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Biol Chem. 2002 Jul 26;277(30):27312-8
pubmed: 11976327
J Biol Chem. 2019 Sep 27;294(39):14442-14453
pubmed: 31406019
Front Chem. 2014 Jun 23;2:40
pubmed: 25003103
J Biomed Mater Res A. 2014 Jul;102(7):2189-96
pubmed: 23913780
J Biol Chem. 2011 Jan 21;286(3):2041-6
pubmed: 21071452
J Biol Chem. 2005 May 13;280(19):19343-9
pubmed: 15753081
Anal Biochem. 1981 Jan 15;110(2):360-8
pubmed: 7015914
Microb Cell Fact. 2012 Nov 05;11:146
pubmed: 23126526
Biomaterials. 2020 May;240:119857
pubmed: 32085975
J Struct Biol. 2014 Jun;186(3):451-61
pubmed: 24434612
Mater Horiz. 2022 Oct 31;9(11):2698-2721
pubmed: 36189465
J Biol Chem. 2012 Feb 3;287(6):4368-75
pubmed: 22179614
Biophys J. 2011 Jul 20;101(2):449-58
pubmed: 21767498
Appl Microbiol Biotechnol. 2014 Feb;98(4):1807-15
pubmed: 24402415
Acta Biomater. 2010 Oct;6(10):3969-77
pubmed: 20466083
J Biol Chem. 2016 Dec 30;291(53):27073-27086
pubmed: 27799304
Biomaterials. 2010 Apr;31(10):2755-61
pubmed: 20056274
ACS Biomater Sci Eng. 2018 Aug 13;4(8):2934-2942
pubmed: 33435015
Biomaterials. 2015 Jun;54:213-25
pubmed: 25907054
J Mol Biol. 1979 Jan 15;127(2):203-16
pubmed: 430563
Acta Biomater. 2017 Mar 15;51:75-88
pubmed: 28087486
J Biomed Mater Res A. 2017 Mar;105(3):806-813
pubmed: 27806444
Acta Biomater. 2012 Mar;8(3):1010-21
pubmed: 22142564
Biomaterials. 2016 Aug;99:56-71
pubmed: 27214650
ACS Biomater Sci Eng. 2021 Apr 12;7(4):1414-1427
pubmed: 33733733
Adv Healthc Mater. 2016 Jul;5(13):1656-66
pubmed: 27219220
J Biol Chem. 2016 Sep 2;291(36):19196-207
pubmed: 27432884
J Struct Biol. 2018 Sep;203(3):255-262
pubmed: 29758270
Nat Biotechnol. 2004 Jul;22(7):877-82
pubmed: 15195104
J Biol Chem. 2008 Dec 5;283(49):34337-44
pubmed: 18845533
Arch Biochem Biophys. 1983 Jun;223(2):562-71
pubmed: 6344798
Appl Microbiol Biotechnol. 2006 Aug;72(1):109-115
pubmed: 16552563
Protein Sci. 2009 Jun;18(6):1241-51
pubmed: 19472339
J Biol Chem. 2014 Feb 21;289(8):5122-33
pubmed: 24356966
Front Bioeng Biotechnol. 2022 Mar 17;10:840939
pubmed: 35372322
Adv Wound Care (New Rochelle). 2015 Aug 1;4(8):444-456
pubmed: 26244101